Cellectar Biosciences Price to Free Cash Flow Ratio 2010-2025 | CLRB
Historical price to free cash flow ratio values for Cellectar Biosciences (CLRB) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cellectar Biosciences Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-11 | 4.88 | 0.00 | |
| 2025-03-31 | 9.46 | $-30.97 | 0.00 |
| 2024-12-31 | 8.97 | $-38.55 | 0.00 |
| 2024-09-30 | 64.20 | $-47.30 | 0.00 |
| 2024-06-30 | 75.00 | $-64.53 | 0.00 |
| 2024-03-31 | 119.40 | $-76.22 | 0.00 |
| 2023-12-31 | 83.10 | $-81.68 | 0.00 |
| 2023-09-30 | 79.20 | $-82.33 | 0.00 |
| 2023-06-30 | 58.50 | $-93.98 | 0.00 |
| 2023-03-31 | 42.90 | $-102.55 | 0.00 |
| 2022-12-31 | 51.30 | $-108.31 | 0.00 |
| 2022-09-30 | 100.80 | $-120.28 | 0.00 |
| 2022-06-30 | 121.14 | $-110.18 | 0.00 |
| 2022-03-31 | 206.34 | $-118.12 | 0.00 |
| 2021-12-31 | 199.20 | $-122.85 | 0.00 |
| 2021-09-30 | 277.50 | $-187.45 | 0.00 |
| 2021-06-30 | 357.00 | $-134.51 | 0.00 |
| 2021-03-31 | 483.00 | $-129.11 | 0.00 |
| 2020-12-31 | 624.00 | $-212.12 | 0.00 |
| 2020-09-30 | 372.00 | $-284.88 | 0.00 |
| 2020-06-30 | 384.00 | $-365.84 | 0.00 |
| 2020-03-31 | 399.93 | $-393.65 | 0.00 |
| 2019-12-31 | 675.00 | $-458.50 | 0.00 |
| 2019-09-30 | 600.00 | $-666.40 | 0.00 |
| 2019-06-30 | 654.00 | $-436.09 | 0.00 |
| 2019-03-31 | 705.00 | $-801.88 | 0.00 |
| 2018-12-31 | 465.00 | $-1,193.52 | 0.00 |
| 2018-09-30 | 900.00 | $-1,344.85 | 0.00 |
| 2018-06-30 | 1860.00 | $-2,094.62 | 0.00 |
| 2018-03-31 | 3405.00 | $-2,238.37 | 0.00 |
| 2017-12-31 | 4110.00 | $-2,432.78 | 0.00 |
| 2017-09-30 | 5010.00 | $-1,904.79 | 0.00 |
| 2017-06-30 | 4890.00 | $-1,333.14 | 0.00 |
| 2017-03-31 | 6810.00 | $-763.45 | 0.00 |
| 2016-12-31 | 3660.00 | $-1.92 | 0.00 |
| 2016-09-30 | 8130.00 | $-2.75 | 0.00 |
| 2016-06-30 | 10320.00 | $-5.38 | 0.00 |
| 2016-03-31 | 10254.90 | $-9.43 | 0.00 |
| 2015-12-31 | 22050.00 | $-10.59 | 0.00 |
| 2015-09-30 | 59100.00 | $-26.94 | 0.00 |
| 2015-06-30 | 86400.00 | $-23.79 | 0.00 |
| 2015-03-31 | 93300.00 | $-21.59 | 0.00 |
| 2014-12-31 | 92700.00 | $-19.33 | 0.00 |
| 2014-09-30 | 66600.00 | $-2.37 | 0.00 |
| 2014-06-30 | 191700.00 | $-3.54 | 0.00 |
| 2014-03-31 | 234000.00 | $-4.20 | 0.00 |
| 2013-12-31 | 222000.00 | $-3.33 | 0.00 |
| 2013-09-30 | 216000.00 | $-2.35 | 0.00 |
| 2013-06-30 | 276000.00 | $-1.48 | 0.00 |
| 2013-03-31 | 276300.00 | $-0.15 | 0.00 |
| 2012-12-31 | 444000.00 | $-0.16 | 0.00 |
| 2012-09-30 | 630000.00 | $-0.20 | 0.00 |
| 2012-06-30 | 714000.00 | $-0.22 | 0.00 |
| 2012-03-31 | 510000.00 | $-0.28 | 0.00 |
| 2011-12-31 | 264000.00 | $-0.25 | 0.00 |
| 2011-09-30 | 762000.00 | $-866.76 | 0.00 |
| 2011-06-30 | 780000.00 | $-866.76 | 0.00 |
| 2011-03-31 | 1000000.00 | $-863.12 | 0.00 |
| 2010-12-31 | 1000000.00 | $-866.85 | 0.00 |
| 2010-09-30 | 1000000.00 | $-0.26 | 0.00 |
| 2010-06-30 | 1000000.00 | $-0.21 | 0.00 |
| 2010-03-31 | 1000000.00 | $-3.76 | 0.00 |
| 2009-12-31 | 1000000.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.009B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.442B | 27.95 |
| Boston Scientific (BSX) | United States | $153.655B | 38.47 |
| Stryker (SYK) | United States | $150.679B | 31.51 |
| EssilorLuxottica (ESLOY) | France | $135.238B | 0.00 |
| Medtronic (MDT) | Ireland | $114.659B | 16.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.418B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.416B | 25.92 |
| ResMed (RMD) | United States | $37.840B | 28.42 |
| Agilent Technologies (A) | United States | $35.272B | 22.99 |
| GE HealthCare Technologies (GEHC) | United States | $35.028B | 16.63 |
| Terumo (TRUMY) | Japan | $24.711B | 32.10 |
| Koninklijke Philips (PHG) | Netherlands | $23.746B | 16.66 |
| Insulet (PODD) | United States | $20.930B | 82.15 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.825B | 12.09 |
| Baxter (BAX) | United States | $15.241B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.608B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.072B | 24.61 |
| Lantheus Holdings (LNTH) | United States | $5.800B | 14.63 |
| Prestige Consumer Healthcare (PBH) | United States | $3.832B | 17.12 |
| Haemonetics (HAE) | United States | $3.755B | 17.10 |
| Perrigo (PRGO) | Ireland | $3.749B | 9.50 |
| Envista Holdings (NVST) | United States | $3.512B | 29.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.378B | 24.91 |
| QuidelOrtho (QDEL) | United States | $2.134B | 14.67 |
| LeMaitre Vascular (LMAT) | United States | $1.937B | 43.31 |
| AtriCure (ATRC) | United States | $1.587B | 0.00 |
| Acuren (TIC) | United States | $1.427B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.357B | 30.52 |
| AdaptHealth (AHCO) | United States | $1.275B | 12.94 |
| Phibro Animal Health (PAHC) | United States | $1.262B | 16.14 |
| Neogen (NEOG) | United States | $1.211B | 15.50 |
| BioLife Solutions (BLFS) | United States | $1.087B | 0.00 |
| InMode (INMD) | Israel | $0.960B | 9.67 |
| Curaleaf Holdings (CURLF) | Canada | $0.818B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.780B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.736B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.641B | 0.00 |
| Owens & Minor (OMI) | United States | $0.640B | 5.31 |
| Evolus (EOLS) | United States | $0.627B | 0.00 |
| CeriBell (CBLL) | United States | $0.606B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.521B | 0.00 |
| Valneva SE (VALN) | France | $0.511B | 0.00 |
| Surmodics (SRDX) | United States | $0.444B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.352B | 12.94 |
| Cresco Labs (CRLBF) | United States | $0.342B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.307B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Cerus (CERS) | United States | $0.296B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 78.17 |
| ZimVie (ZIMV) | United States | $0.262B | 11.90 |
| Brainsway (BWAY) | Israel | $0.239B | 63.17 |
| Biote (BTMD) | United States | $0.230B | 6.48 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Omeros (OMER) | United States | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.14 |
| Vireo Growth (VREOF) | United States | $0.164B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.25 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.91 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.57 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |